Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 6,135  205.00  3.23%   
About 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Teva to buy Barr for 7.46 bln, boost generic lead - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Ltd Down 1.44 percent in Premarket Trading - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharma is the way to play the re-rise of generic drugs - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Global Postmenopausal Osteoporosis Treatment Market is - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Pulmonary Drug Delivery Devices Market to Exceed Value of USD ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Topical Antibiotic Pharmaceuticals Market Paving the Way for a ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Tue TASE sustains rally - Globes - Globes
Google News at Macroaxis
over a year ago at news.google.com         
HIV Drugs Market to Reach 51.1 Billion, Globally, by 2032 at 4.5 ... - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Teva beats on Q3 revenue and raises guidance - Globes
Google News at Macroaxis
over a year ago at news.google.com         
Pre-Market Earnings Report for November 8, 2023 TRP, BIIB, WBD ... - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Strong week for Teva Pharmaceutical Industries NYSETEVA ... - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical Industries Shares Cross Above 200 DMA - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical Industries Enters Oversold Territory - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Teva to Provide Second Round of Funding to Clinics in California ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Pediatric Vaccines Market Size Ascends Estimated USD 98.8 Billion ... - GlobeNewswire
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world